Literature DB >> 28342916

Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: The NIH experience.

Beatriz E Marciano1, Elisabeth S Allen2, Cathy Conry-Cantilena2, Ervand Kristosturyan1, Harvey G Klein2, Thomas A Fleisher3, Steven M Holland1, Harry L Malech4, Sergio D Rosenzweig5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28342916      PMCID： PMC5546986          DOI： 10.1016/j.jaci.2017.02.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Azole antifungals: 35 years of invasive fungal infection management.

Authors:  David Allen; Dustin Wilson; Richard Drew; John Perfect
Journal:  Expert Rev Anti Infect Ther       Date:  2015-04-05       Impact factor: 5.091

2.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

3.  Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.

Authors:  Aydan Ikincioğullari; Figen Dogu; Nuri Solaz; Ismail Reisli; Sabri Kemahli; Sükrü Cin; Emel Babacan
Journal:  Ther Apher Dial       Date:  2005-04       Impact factor: 1.762

Review 4.  Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction.

Authors:  S J Stanworth; E Massey; C Hyde; S Brunskill; G Lucas; C Navarrete; D I Marks
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

5.  Alloimmunization after granulocyte transfusions.

Authors:  D F Stroncek; K Leonard; G Eiber; H L Malech; J I Gallin; S F Leitman
Journal:  Transfusion       Date:  1996 Nov-Dec       Impact factor: 3.157

Review 6.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-22       Impact factor: 3.722

7.  Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.

Authors:  Thomas H Price; Michael Boeckh; Ryan W Harrison; Jeffrey McCullough; Paul M Ness; Ronald G Strauss; W Garrett Nichols; Taye H Hamza; Melissa M Cushing; Karen E King; Jo-Anne H Young; Eliot Williams; Janice McFarland; Jennifer Holter Chakrabarty; Steven R Sloan; David Friedman; Samir Parekh; Bruce S Sachais; Joseph E Kiss; Susan F Assmann
Journal:  Blood       Date:  2015-09-02       Impact factor: 22.113

8.  Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report.

Authors:  Mark Parta; Dianne Hilligoss; Corin Kelly; Nana Kwatemaa; Narda Theobald; Harry Malech; Elizabeth M Kang
Journal:  J Clin Immunol       Date:  2015-10-09       Impact factor: 8.317

Review 9.  Update on granulocyte transfusions: accumulation of promising data, but still lack of decisive evidence.

Authors:  Satoshi Yoshihara; Junko Ikemoto; Yoshihiro Fujimori
Journal:  Curr Opin Hematol       Date:  2016-01       Impact factor: 3.284
  9 in total
  9 in total

1.  Revisiting Fatal Granulomatous Disease of Childhood Through an Autopsy: Still Lethal in the Developing World!

Authors:  Rakesh Kumar Pilania; Ashwini Prithvi; Kaniyappan Nambiyar; Kirti Gupta; Amit Rawat
Journal:  J Clin Immunol       Date:  2019-03-21       Impact factor: 8.317

Review 2.  Granulocyte transfusions: A concise review for practitioners.

Authors:  Juan Gea-Banacloche
Journal:  Cytotherapy       Date:  2017-09-12       Impact factor: 5.414

3.  Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia.

Authors:  Prashant Hiwarkar; Stuart Adams; Kimberly Gilmour; Ramya Nataraj; Denise Bonney; Kay Poulton; Robert Wynn
Journal:  Blood Adv       Date:  2020-09-08

4.  NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease.

Authors:  Suk See De Ravin; Julie Brault; Ronald J Meis; Linhong Li; Narda Theobald; Aylin C Bonifacino; Hong Lei; Taylor Q Liu; Sherry Koontz; Cristina Corsino; Marissa A Zarakas; Jigar V Desai; Aaron B Clark; Uimook Choi; Mark E Metzger; Kamille West; Steven L Highfill; Elizabeth Kang; Douglas B Kuhns; Michail S Lionakis; David F Stroncek; Cynthia E Dunbar; John F Tisdale; Robert E Donahue; Gary A Dahl; Harry L Malech
Journal:  Blood Adv       Date:  2020-12-08

Review 5.  Advances and highlights in primary immunodeficiencies in 2017.

Authors:  Javier Chinen; Morton J Cowan
Journal:  J Allergy Clin Immunol       Date:  2018-08-29       Impact factor: 10.793

6.  Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections.

Authors:  David B Sykes; Michelle M Martinelli; Paige Negoro; Shuying Xu; Katrina Maxcy; Kyle Timmer; Adam L Viens; Natalie J Alexander; Johnny Atallah; Brendan D Snarr; Shane R Baistrocchi; Natalie J Atallah; Alex Hopke; Allison Scherer; Ivy Rosales; Daniel Irimia; Donald C Sheppard; Michael K Mansour
Journal:  J Leukoc Biol       Date:  2022-03-31       Impact factor: 6.011

Review 7.  Chronic Granulomatous Disease: a Comprehensive Review.

Authors:  Hsin-Hui Yu; Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

Review 8.  Recent advances in understanding and treating chronic granulomatous disease.

Authors:  Andrew Gennery
Journal:  F1000Res       Date:  2017-08-11

9.  Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseudogenes.

Authors:  Denise Klatt; Erica Cheng; Friederike Philipp; Anton Selich; Julia Dahlke; Reinhold E Schmidt; Juliane W Schott; Hildegard Büning; Dirk Hoffmann; Adrian J Thrasher; Axel Schambach
Journal:  Stem Cell Reports       Date:  2019-09-19       Impact factor: 7.765
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.